Clinical Trials and New Cancer Drugs: What Patients in India Should Know

Last updated: November 2026. This article is for general education and does not replace advice from your own oncologist.

When a doctor says the word “trial,” many patients and families go quiet. Some feel hope. Others feel fear. A lot of people quietly wonder, “Does this mean nothing else is left for me?”

The short answer is no. A clinical trial is not a last resort. It is a carefully planned study that tests whether a new way of treating or detecting cancer is safe and whether it works better than what we use today. Many of the cancer medicines that save lives now, including several targeted therapies and immunotherapies, were once tested in trials.

In this guide, you will learn how clinical trials work, how new cancer drugs reach patients in India, who can join, what the real benefits and risks are, and which questions to ask before you decide. We have kept the language simple, because a decision this big should never be buried in jargon.

What Is a Clinical Trial?

A clinical trial is a research study that involves people. Doctors use it to answer a clear question, such as:

• Is this new drug safe?
• Does it shrink tumours or help people live longer?
• Is it better than the treatment we already use?
• Can a different dose, schedule, or combination work better with fewer side effects?

Trials can test new drugs, new combinations of existing drugs, new radiation techniques, new surgical methods, and even new screening tests. Some trials also study supportive care, such as ways to reduce nausea, pain, or fatigue.

It helps to know the difference between three terms that often get mixed up:

• Standard treatment: The treatment that has already been proven in earlier research and is accepted as the best available choice.
• Clinical trial treatment: A treatment that is still being studied under strict rules, with close monitoring.
• Unproven treatment outside a trial: A treatment sold or offered without proper approval and oversight. This is not the same as a trial, and it carries much higher risk.

A genuine trial always has a written plan, called a protocol, which has been reviewed by an independent ethics committee. If someone offers you an “experimental cure” without any of this paperwork, that is a warning sign.

The Four Phases of Cancer Clinical Trials

New treatments move through stages. Each stage answers a different question, and each one involves more patients than the last.

Phase	Main question	Typical size	What it means for you
Phase I	Is it safe, and what dose is right?	Small group, often 20 to 80	Highest level of uncertainty, very close monitoring
Phase II	Does it work against this type of cancer?	Dozens to a few hundred	Early signs of benefit are being measured
Phase III	Is it better than the current standard?	Hundreds to thousands	You may receive the new treatment or the standard one
Phase IV	What happens over the long term after approval?	Large, real-world groups	The drug is already approved, and safety tracking continues

Phase I trials are the first time a drug is tested in people. The focus is on safety and finding a dose that can be given without causing serious harm.

Phase II trials look at whether the drug actually helps, for example by shrinking a tumour or delaying its growth.

Phase III trials are the big comparison studies. Patients are usually assigned by chance, which is called randomisation, to receive either the new treatment or the current standard. This is how doctors learn whether the new option is truly better.

Phase IV studies happen after a drug is approved. They look for rare side effects and long-term results in a wider group of patients.

If your doctor suggests a trial, always ask which phase it is. The answer tells you a lot about what is known and what is still uncertain.

How New Cancer Drugs Get Approved in India

In India, new drugs and clinical trials are regulated by the Central Drugs Standard Control Organisation, known as CDSCO, under the New Drugs and Clinical Trials Rules, 2019. These rules set out what a sponsor must do before a trial begins and how patients must be protected during it.

Here is the basic path in plain words:

1. Laboratory and animal studies. Researchers first test a drug outside the human body to look for safety and promise.
2. Permission to run a trial. The sponsor applies to the regulator, and the trial protocol must also be approved by an ethics committee at each hospital taking part.
3. Trial registration. Trials conducted in India must be registered with the Clinical Trials Registry India, called CTRI, which is a public database. Anyone can search it.
4. Trial phases. The drug moves through the phases described above.
5. Marketing approval. If the results show that benefits outweigh risks, the regulator may approve the drug for use in India. In some cases, data from trials done in other countries is reviewed alongside Indian data.

Why do some new drugs reach India later?

Patients often ask why a medicine available abroad is not yet available here. There are a few common reasons. The company may not have applied yet. The regulator may ask for more data on Indian patients. Or the pricing and supply plans may still be in progress.

This is one reason global trials that include Indian hospitals matter. When Indian patients take part, doctors learn how the drug performs in our population, and patients may get earlier access to promising treatments under careful supervision.

Indian researchers and institutions, including bodies like the Indian Council of Medical Research, have also issued ethical guidelines for biomedical research on people. These guidelines stress consent, safety, and fairness, and they shape how responsible hospitals run studies.

Who Can Join a Cancer Clinical Trial?

Every trial has rules about who can take part. These are called eligibility criteria. They are not there to shut people out. They exist to keep patients safe and to make sure the results are clear and reliable.

Common factors include:

• The exact type and stage of cancer
• Results of biomarker or genetic tests on the tumour
• Treatments you have had before, and how you responded
• Your age and overall fitness
• Blood test results and how well your liver, kidneys, and heart are working
• Other health conditions and medicines you take

Many modern trials are built around biomarkers. For example, a drug may be designed only for tumours that carry a certain gene change. In that case, proper testing of your tumour sample is the key that opens the door to the trial.

A practical tip: keep all your reports organised. Biopsy reports, scans, pathology slides, blood tests, and a list of past treatments help the research team check your eligibility faster. Missing reports are one of the most common reasons screening gets delayed.

Also remember that you can be told “not eligible” for one trial and still be a good fit for another. It does not reflect on you or your chances with standard care.

Benefits and Risks of Joining a Trial

Joining a trial is a personal decision. There is no single right answer. The table and lists below show both sides honestly.

Pros of joining a clinical trial

• Access to newer treatment. You may receive a therapy that is not yet widely available.
• Close monitoring. Trial patients are usually checked more often, with regular scans and tests.
• Expert attention. Trials are run by specialist teams who follow a strict plan.
• Possible cost support. In many trials, the study drug and trial-related tests are provided by the sponsor, though you should always confirm what is covered.
• Helping others. Your participation can improve care for future patients.

Cons of joining a clinical trial

• Unknown side effects. A new treatment may cause problems that are not yet fully understood.
• No guarantee of benefit. The new drug may work no better than the standard one, or may not work at all.
• Chance of the standard arm. In randomised trials, you might receive the existing standard treatment instead of the new one.
• More time and effort. Extra visits, tests, and paperwork can be tiring, especially if the centre is far from home.
• Strict rules. You may need to follow a fixed schedule and avoid certain other medicines or supplements.

Standard treatment vs clinical trial at a glance

Factor	Standard treatment	Clinical trial
Evidence	Proven in earlier research	Still being tested
Access to newest options	Limited to approved drugs	May include very new options
Monitoring	Regular, as per usual care	Often more frequent and detailed
Certainty of results	Better known	Less certain
Extra visits and tests	Fewer	Usually more
Cost	Patient or insurer pays	Study drug and some tests often covered by sponsor
Right to leave	Yes	Yes, at any time

Neither column is automatically better. For some patients, standard treatment is the wisest choice. For others, a well-designed trial offers real hope. The best way to decide is to talk openly with your oncologist about your specific situation.

Your Rights and Safety Protections as a Patient in India

Trust is built on clear rules. Indian regulations place several protections around trial participants.

Informed consent. Before joining, you must be given full information about the trial in a language you understand. This covers the purpose, procedures, possible risks and benefits, alternatives, and who to contact with questions. Indian rules also require the consent process to be documented, and in many cases audio-visual recording of the process is part of the requirement. You have the right to take the form home, discuss it with family, and ask for more time.

Freedom to withdraw. You can leave a trial at any point, for any reason. Leaving does not mean you lose your right to proper medical care.

Ethics committee oversight. An independent committee reviews the trial before it starts and continues to watch over it. Its job is to protect participants.

Compensation for harm. Under the New Drugs and Clinical Trials Rules, 2019, participants who suffer trial-related injury are entitled to medical care and financial compensation, and there are provisions for compensation in case of trial-related death.

Privacy. Your personal and medical information must be kept confidential and used only for the purposes you agreed to.

If any part of the consent form feels confusing, ask the doctor or research coordinator to explain it again. A good team will never rush you.

Common Myths About Clinical Trials

Myth 1: “I will be treated like a guinea pig.” Fact: Trial participants are protected by consent rules, ethics review, and constant monitoring. Safety comes first.

Myth 2: “Trials are only for people who have no options left.” Fact: Many trials enrol patients at early stages, and some test treatments given right after diagnosis. Others are for people who have tried standard options, but that is only one group.

Myth 3: “I might get a fake pill and no treatment.” Fact: In cancer research, patients are almost never given a placebo alone in place of needed treatment. Usually the comparison is the new treatment against the best known standard, or a placebo added on top of standard care.

Myth 4: “New means better.” Fact: New does not always mean better. That is exactly why trials are done. Sometimes the new drug turns out to be no better, or less suitable, than the standard.

Myth 5: “If I join, I cannot change my mind.” Fact: You can withdraw at any time.

At a specialist centre such as Subha Comprehensive Cancer Care, a multidisciplinary team can review your reports, explain which treatments are proven and which are still under study, and help you weigh your options before you decide anything.

Questions to Ask Your Oncologist Before Deciding

Going into the conversation with a list can calm your nerves and keep you in control. Consider asking:

1. What is the goal of this trial, and which phase is it?
2. What are the standard treatment options if I do not join?
3. What do we already know about this drug’s side effects?
4. How might this affect my daily life, work, and family?
5. Will I get the new drug for sure, or could I be assigned to the standard treatment?
6. Who pays for the drug, the scans, the hospital stay, and any trial-related complications?
7. How often will I need to visit, and for how long?
8. What happens if I want to stop?
9. Who do I call if I feel unwell at night or on a weekend?
10. Is it all right if I take a second opinion before deciding?

Write the answers down, or ask a family member to join you and take notes. Big decisions are easier when you do not have to remember everything alone.

How to Find a Genuine Clinical Trial in India

Finding a trustworthy trial takes a little care. Here is a simple approach.

1. Start with your treating oncologist. They know your medical history and can tell you whether a trial fits your situation.
2. Search the CTRI database. It lists trials registered in India, and you can search by cancer type or location.
3. Check for ethics committee approval. A genuine trial will be able to tell you which committee approved it.
4. Look for a named principal investigator. This is the doctor responsible for the trial at that site.
5. Ask for the written consent form and information sheet. A real trial will always have them.

Red flags to watch for

• You are asked to pay a fee just to join
• Someone promises a cure or guaranteed results
• You are pressured to decide quickly
• There is no written consent form or information sheet
• The team cannot show you any registration or approval details
• The treatment is advertised through social media messages or unknown agents

If anything feels wrong, pause and get a second opinion from a trusted specialist.

Frequently Asked Questions

Are cancer clinical trials safe in India?

Trials in India must follow national regulations, ethics committee review, and informed consent rules. No trial is risk free, but these safeguards exist to protect participants. Always choose a trial run through a recognised hospital and registered on CTRI.

Do I have to pay to join a clinical trial?

In many trials, the sponsor covers the study drug and certain trial-related tests. Other costs, such as regular care, travel, and stay, may still be yours. Ask for a clear written explanation of what is and is not covered.

Can I leave a trial after I start?

Yes. You can withdraw at any time without losing your right to standard care.

Will joining a trial affect my regular treatment?

It depends on the trial. Some trials replace part of your usual treatment, while others add to it. Your oncologist should explain exactly how your care will change.

Can I join a trial if I have already had chemotherapy?

Often yes. Some trials are designed specifically for people who have had earlier treatments. Others need patients who have not yet been treated. Eligibility depends on the trial.

Are new cancer drugs always better than older ones?

No. New drugs can be more effective, but they can also have different side effects or turn out to be no better. Trials exist to find that out in a fair and careful way.

Should I get a second opinion before joining a trial?

Yes, if you can. A second opinion can confirm that the trial is a sensible choice for your type and stage of cancer and help you feel more confident in your decision.

Final Thoughts

Clinical trials are how cancer care moves forward. In India, they run under national rules designed to protect patients, and every participant has the right to understand, ask questions, and leave at any time.

A trial is not a sign that you have run out of options, and it is not a promise of a miracle. It is one possible path among several, and it deserves a calm and honest conversation.

Take your time. Gather your reports. Bring your questions. Speak with a qualified oncology team, and consider a second opinion if you are unsure. The right decision is the one that is informed, unhurried, and made with people you trust.

Disclaimer: This article is for educational purposes only. It does not provide medical advice, diagnosis, or treatment. Always consult a qualified oncologist about your own condition and treatment choices.